Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-227
J Cardiovasc Pharmacol 2006 May 01;475:656-62. doi: 10.1097/01.fjc.0000211753.47067.cc.
Show Gene links Show Anatomy links

The D3-dopaminergic agonist 7-hydroxy-dipropylaminotetralin (7-OH-DPAT) increases cardiac action potential duration and blocks human ether-a-go-go-related gene K+ channel.

Torres-Jácome J , Tejeda-Chávez HR , Rodríguez-Menchaca AA , Sánchez-Chapula JA , Navarro-Polanco RA .


???displayArticle.abstract???
The D3-dopaminergic agonist (+/-) 7-hydroxy-dipropylaminotetralin (7-OH-DPAT) prolonged cycle length and action potential duration, depolarized maximum diastolic potential, and reduced the upstroke velocity of the action potential of rabbit sinoatrial node cells. These effects were not mediated by D3-dopaminergic receptors. In cat Purkinje fibers, the drug increased action potential duration. In voltage-clamped cat ventricular myocytes, 7-OH-DPAT blocked the rapid component of the delayed rectifier potassium current, IKr. This effect was corroborated in experiments studying the effect of the drug on human Ether-a-go-go-related Gene channels expressed in Xenopus oocytes and in HEK293 cells. We conclude that the direct electrophysiologic effects of 7-OH-DPAT on cardiac tissues are caused by the blockade of the rapid component of the delayed rectifier potassium current, IKr.

???displayArticle.pubmedLink??? 16775504
???displayArticle.link??? J Cardiovasc Pharmacol


Species referenced: Xenopus
Genes referenced: cat.2 dio3 gnao1 kcnh1